About Us
About Guard Therapeutics
Vision, mission & goal
The Board
Management
Research & Development
Acute kidney injury
RMC-035 (ROSgard)
Clinical development
Patents
Investor Relations
Financial calender
Financial reports
Share information
Corporate governance
General meetings
News & Media
Press releases
Event calender
Analyses and presentations
In media
Subscribe
Contact
Swe
Search
Financial calender
09 May 2023
/
Annual General Meeting 2023 (including Annual Report 2022)
09 May 2023
/
Interim report January-March 2023
24 Aug 2023
/
Interim report April-June 2023
10 Nov 2023
/
Interim report July-September 2023
21 Feb 2024
/
Year-end report 2023